leisure time -WSS

leisure time

author：knowledge 2025-10-02 03:40:10 Page View：41418

STAT Q&A — Paul Matteis (right), in 2017 with then-colleagues Seamus Fernandez (far left) Geoffrey Porges. Alex Hogan/STAT

NEW YORK — Is biotech having a renaissance in neuroscience? Can we solve the placebo effect? And what’s going to happen next year?

Paul Matteis, co-head of biotech research at Stifel, sat down with STAT at the firm’s annual health care conference here to field those questions and opine on how management teams can walk the delicate balance between hype and sandbagging. This transcript has been edited for length and clarity.

One thing I’ve been hearing lately is that biotech has entered a sort of renaissance in neuroscience. Do you agree with that?

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Why rehabilitation engineers need to center patients in their research
Next article： Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

explore

Jerome Adams on the need for new antivirals for Covid

PaxlovidtabletsamplesbeinginspectedinFreiburg,Germany.PfizerviaAPTheU.S.Covid-19Public HealthEmergen

Health care needs a new profession: neuroimaging counseling

AnMRIscanimageofabrainALAINJOCARD/AFPviaGettyImagesUntilrecently,gettinganMRImeanttravelingtothehosp

Guidelines to prevent youth baseball injuries need more muscle

Apitcheratthe2018LittleLeagueWorldSeries.RobCarr/GettyImages“Weallknowthatweareinthemiddleofanepidem

H5N1 bird flu virus started spreading in cows in Texas in December

ColorizedmicroscopicimageofH5N1birdfluvirusparticles(inyellow).NIAIDAsagriculturalauthoritiesandepid